Contego Medical logo

Contego Medical

Integrated embolic protection and thrombectomy devices for vascular procedures.

ShareLink copied

The record

Vertical
Cardiovascular
Sub-segment
Carotid and peripheral vascular devices
Product type
Device
Headquarters
Raleigh, NC, United States
Region
North America

What they do

Contego Medical develops carotid and peripheral vascular devices, including Neuroguard IEP and Excipio. Ravish Sachar, MD, and Jay Yadav, MD, founded the company. On 16 November 2026, Medtronic announced its intent to acquire Contego for $380 million plus potential payments, with closing expected in Medtronic's fiscal third quarter. Neuroguard IEP Direct received FDA PMA approval, with 510(k) clearance for its embolic protection system announced on 10 November. The company reported 0% 30-day stroke in the PERFORMANCE III intention-to-treat population and a 0.69% major adverse event rate; these are study-specific results.

History and progression

How Contego Medical got here, step by step.

  1. 16 November 2026

    Planned Medtronic acquisition

    Medtronic announced a $380 million acquisition agreement plus potential payments, with closing expected in its fiscal third quarter subject to customary conditions.

Recent news

  1. 16 November 2026

    Contego Medical announcement
  2. 16 November 2026

    Ravish Sachar, Founder and CEO
  3. 16 November 2026

    Jay Yadav, Co-founder
  4. 16 November 2026

    Contego Medical Planned acquisition details

Related companies

Is this your company? Get a Verified profile